Tohid Kazemi

发表

The Role of V-Domain Ig Suppressor of T Cell Activation (VISTA) in Cancer Therapy: Lessons Learned and the Road Ahead

B. Baradaran, A. Mokhtarzadeh, A. Derakhshani, 2021, Frontiers in Immunology.

Investigating the Association of ADAM33 Single Nucleotide Polymorphisms (SNPs) with Susceptibility to Allergic Asthma in Azerbaijan Population of Iran: A Case-control Study.

S. Sadigh-Eteghad, A. Razavi, Z. Babaloo, 2017, Iranian journal of allergy, asthma, and immunology.

Placental Kisspeptins Differentially Modulate Vital Parameters of Estrogen Receptor-Positive and -Negative Breast Cancer Cells

A. Zarnani, S. Rezania, E. Mirzadegan, 2016, PloS one.

Inflammatory and immunological changes caused by noise exposure: A systematic review

Y. Rasoulzadeh, M. Mesgari-Abbasi, Tohid Kazemi, 2020, Journal of environmental science and health. Part C, Toxicology and carcinogenesis.

New Insights Into the Relationship Between Chitinase-3-Like-1 and Asthma

Anton P. Bussink, Tohid Kazemi, Daniel Elieh Ali Komi, 2016, Current Allergy and Asthma Reports.

Gene therapy with IL-12 induced enhanced anti-tumor activity in fibrosarcoma mouse model

B. Baradaran, D. Shanehbandi, F. Lotfipour, 2016, Artificial cells, nanomedicine, and biotechnology.

Effect of Cellular-Based Artificial Antigen Presenting Cells Expressing ICOSL, in T-cell Subtypes Differentiation and Activation

B. Baradaran, H. Nozad Charoudeh, Tohid Kazemi, 2020, Advanced pharmaceutical bulletin.

miR-486-5p regulates cell proliferation and migration in breast cancer

B. Baradaran, A. Salehzadeh, Tohid Kazemi, 2020 .

The combination effect of Prominin1 (CD133) suppression and Oxaliplatin treatment in colorectal cancer therapy.

B. Baradaran, D. Shanehbandi, A. Mokhtarzadeh, 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Chemotherapeutic Agents Increase PD-L1 Expression in A549 Lung Cancer Cell Line

B. Baradaran, D. Shanehbandi, A. Baghbanzadeh, 2021 .

Large Scale Generation and Characterization of Anti-Human CD34 Monoclonal Antibody in Ascetic Fluid of Balb/c Mice.

B. Baradaran, Leili Aghebati Maleki, J. Majidi, 2013, Advanced pharmaceutical bulletin.

Association of IL-13 single nucleotide polymorphisms in Iranian patients to multiple sclerosis.

H. Sadeghi-Bazargani, M. Farhoudi, Z. Babaloo, 2014, American journal of clinical and experimental immunology.

Docosahexaenoic acid may inhibit immune evasion of colorectal cancer cells through targeting immune checkpoint and immunomodulator genes and their controlling microRNAs

B. Baradaran, D. Shanehbandi, Tohid Kazemi, 2022, BioFactors.

Acellular Wharton’s Jelly, Potentials in T-Cell Subtypes Differentiation, Activation and Proliferation

B. Baradaran, H. Nozad Charoudeh, Tohid Kazemi, 2020, Advanced pharmaceutical bulletin.

Docosahexaenoic acid (DHA) inhibits pro-angiogenic effects of breast cancer cells via down-regulating cellular and exosomal expression of angiogenic genes and microRNAs.

B. Baradaran, D. Shanehbandi, Mahsa Javadian, 2020, Life sciences.

Polyclonal Antibody Production against Mouse Purified IgG2a towards Use in Basic Research

M. Ahmadi, J. Majidi, Tohid Kazemi, 2016 .

Cloning and Stable Expression of cDNA Coding For Platelet Endothelial Cell Adhesion Molecule -1 (PECAM-1, CD31) in NIH-3T3 Cell Line.

B. Baradaran, D. Shanehbandi, Tohid Kazemi, 2015, Advanced pharmaceutical bulletin.

Cloning and Expression of CD19, a Human B-Cell Marker in NIH-3T3 Cell Line

B. Baradaran, D. Shanehbandi, Tohid Kazemi, 2015, Avicenna journal of medical biotechnology.

Combined Interleukin 12 and Granulocyte-macrophage Colony-stimulating Factor Gene Therapy Synergistically Suppresses Tumor Growth in the Murine Fibrosarcoma

B. Baradaran, D. Shanehbandi, L. Mohammadnejad, 2017 .

Tumor‐derived exosomal PD‐L1 in progression of cancer and immunotherapy

Parisa Lotfinejad, Tohid Kazemi, S. Rasihashemi, 2021, Journal of cellular physiology.

Promoter region single nucleotide polymorphism of siglec-8 gene associates with susceptibility to allergic asthma.

A. Razavi, Tohid Kazemi, Mahnaz Sadeghi-Shabestrai, 2020, Personalized medicine.

Preparation of Proper Immunogen by Cloning and Stable Expression of cDNA coding for Human Hematopoietic Stem Cell Marker CD34 in NIH-3T3 Mouse Fibroblast Cell Line.

D. Shanehbandi, J. Majidi, Tohid Kazemi, 2015, Advanced pharmaceutical bulletin.

The potential role of toll-like receptor 4 Asp299Gly polymorphism and its association with recurrent cystic echinococcosis in postoperative patients

H. Sadeghi-Bazargani, A. Spotin, E. Ahmadpour, 2018, Parasitology Research.

Investigating the Association of Orosomucoid 1-like 3 (ORMDL3) Gene Polymorphism (rs12603332) with Susceptibility to Allergic Asthma in Iranian Northwestern Azeri Population.

D. Elieh Ali Komi, A. Razavi, Z. Babaloo, 2019, Iranian journal of allergy, asthma, and immunology.

Investigating the Chitinase-3-Like-1 Gene Polymor- phism (rs4950928) With Susceptibility to Allergic Asth- ma in Iranian Northwestern Azeri Population

A. Razavi, Z. Babaloo, Tohid Kazemi, 2020 .

Immunomodulatory Effect of Human Umbilical Cord Blood-derived Mesenchymal Stem Cells on Activated T-lymphocyte.

B. Baradaran, Parisa Lotfinejad, E. Safarzadeh, 2021, Iranian journal of allergy, asthma, and immunology.

DHA Abolishes the Detrimental Effect of Docetaxel on Downregulation of the MICA via Decreasing the Expression Level of MicroRNA-20a in Gastric Cancer

B. Baradaran, M. Darabi, Mahsa Javadian, 2019, Journal of Gastrointestinal Cancer.

The Cytotoxic and Apoptotic Effects of Scrophularia Atropatana Extracts on Human Breast Cancer Cells

B. Baradaran, D. Shanehbandi, L. Mohammadnejad, 2017, Advanced pharmaceutical bulletin.

The effect of combined miR‐200c replacement and cisplatin on apoptosis induction and inhibition of gastric cancer cell line migration

B. Baradaran, B. Mansoori, A. Mohammadi, 2019, Journal of cellular physiology.

Update on Fc receptor-like (FCRL) family: new immunoregulatory players in health and diseases

M. Shabani, Z. Amirghofran, Tohid Kazemi, 2018, Expert opinion on therapeutic targets.

The Predictive Value of HLA-DR Matching and Cytokine Gene Polymorphisms in Renal Allograft Acute Rejection: a Living-unrelated Donor (LURD) Study.

A. Ghods, N. Tajik, Ali-Akbar Delbandi, 2006, Iranian journal of immunology : IJI.

Helicobacter pylori Recombinant CagA Regulates Th1/Th2 Balance in a BALB/c Murine Model

B. Baradaran, M. Aghapour, B. Mansoori, 2020, Advanced pharmaceutical bulletin.

IL‐17 and IL‐22 elicited by a DNA vaccine encoding ROP13 associated with protection against Toxoplasma gondii in BALB/c mice

A. Daryani, A. Spotin, E. Ahmadpour, 2018, Journal of cellular physiology.

Association of CD46 IVS1-1724 C>G Single Nucleotide Polymorphism in Iranian Women with Unexplained Recurrent Spontaneous Abortion (URSA).

Z. Moradi, Tohid Kazemi, A. Monfaredan, 2016, Iranian journal of allergy, asthma, and immunology.

CTLA-4 silencing in dendritic cells loaded with colorectal cancer cell lysate improves autologous T cell responses in vitro

B. Baradaran, M. Santarpia, A. Mokhtarzadeh, 2022, Frontiers in Immunology.

Docosahexaenoic acid (DHA) and linoleic acid (LA) modulate the expression of breast cancer involved miRNAs in MDA-MB-231 cell line.

B. Baradaran, D. Shanehbandi, D. Elieh Ali Komi, 2021, Clinical nutrition ESPEN.

BACH1 silencing by siRNA inhibits migration of HT-29 colon cancer cells through reduction of metastasis-related genes.

B. Baradaran, D. Shanehbandi, B. Mansoori, 2016, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Coinhibition of S1PR1 and GP130 by siRNA‐loaded alginate‐conjugated trimethyl chitosan nanoparticles robustly blocks development of cancer cells

M. Yousefi, F. Atyabi, A. Namdar, 2020, Journal of cellular physiology.

Cytotoxic and Apoptotic Activities of Methanolic Subfractions of Scrophularia oxysepala against Human Breast Cancer Cell Line

A. Pasdaran, B. Baradaran, D. Shanehbandi, 2016, Evidence-based complementary and alternative medicine : eCAM.

Dichloromethane fractions of Scrophularia oxysepala extract induce apoptosis in MCF-7 human breast cancer cells.

A. Pasdaran, B. Baradaran, D. Shanehbandi, 2015, Bosnian journal of basic medical sciences.

The Study of HLA-G Gene and Protein Expression in Patients with Recurrent Miscarriage

B. Baradaran, Leili Aghebati Maleki, L. Farzadi, 2019, Advanced pharmaceutical bulletin.

Overview of Apoptosis, Autophagy, and Inflammatory Processes in Toxoplasma gondii Infected Cells

V. Nissapatorn, E. Ahmadpour, F. Babaie, 2023, Pathogens.

Production and purification of polyclonal antibody against F(ab')2 fragment of human immunoglobulin G

L. Aghebati-Maleki, J. Majidi, Tohid Kazemi, 2017, Veterinary research forum : an international quarterly journal.

Development of a Stable Cell Line, Overexpressing Human T-cell Immunoglobulin Mucin 1.

H. Khanahmad, M. Ganjalikhani-Hakemi, V. Homayouni, 2015, Iranian journal of biotechnology.

Gene therapy, early promises, subsequent problems, and recent breakthroughs.

B. Baradaran, L. Mohammadnejad, F. Lotfipour, 2013, Advanced pharmaceutical bulletin.

Construction of a hepatitis B virus neutralizing chimeric monoclonal antibody recognizing escape mutants of the viral surface antigen (HBsAg)

U. Protzer, M. M. Amiri, J. Khoshnoodi, 2017, Antiviral research.

Recent Advances in Targeting of Breast Cancer Stem Cells Based on Biological Concepts and Drug Delivery System Modification

B. Baradaran, Abbas Ebrahimi-kalan, Khalil Hajiasgharzadeh, 2020, Advanced pharmaceutical bulletin.

Overexpression of HMGA2 in breast cancer promotes cell proliferation, migration, invasion and stemness

H. Ditzel, P. Duijf, B. Baradaran, 2020, Expert opinion on therapeutic targets.

Dendritic cell-based cancer immunotherapy in the era of immune checkpoint inhibitors: From bench to bedside.

B. Baradaran, A. Mokhtarzadeh, Nima Hemmat, 2022, Life sciences.

miR‐142‐3p is a tumor suppressor that inhibits estrogen receptor expression in ER‐positive breast cancer

U. Holmskov, P. Duijf, B. Baradaran, 2019, Journal of cellular physiology.

The role of microRNAs regulating the expression of matrix metalloproteinases (MMPs) in breast cancer development, progression, and metastasis

A. Mohammadi, H. Mohammadi, Meghdad Abdollahpour‐Alitappeh, 2018, Journal of cellular physiology.

Silencing of High Mobility Group Isoform I-C (HMGI-C) Enhances Paclitaxel Chemosensitivity in Breast Adenocarcinoma Cells (MDA-MB-468).

B. Baradaran, D. Shanehbandi, L. Mohammadnejad, 2016, Advanced pharmaceutical bulletin.

Association study of forkhead box P3 gene polymorphisms with unexplained recurrent spontaneous abortion.

M. Jeddi-Tehrani, K. Kamali, S. Zarei, 2015, Journal of reproductive immunology.

Expression analysis of circulating miR-146a and miR-155 as novel biomarkers related to effective immune responses in human cystic echinococcosis.

A. Spotin, E. Ahmadpour, Z. Alizadeh, 2021, Microbial pathogenesis.

Parasite-derived microRNAs in plasma as novel promising biomarkers for the early detection of hydatid cyst infection and post-surgery follow-up.

D. Shanehbandi, Pengfei Cai, A. Spotin, 2020, Acta tropica.

miR‐142‐3p as tumor suppressor miRNA in the regulation of tumorigenicity, invasion and migration of human breast cancer by targeting Bach‐1 expression

U. Holmskov, P. Duijf, B. Baradaran, 2018, Journal of cellular physiology.

Biological effects of IL-21 on different immune cells and its role in autoimmune diseases.

Z. Babaloo, J. Majidi, Tohid Kazemi, 2016, Immunobiology.

Immunotherapeutic approaches for cancer therapy: An updated review

M. Yousefi, V. Younesi, Tohid Kazemi, 2015, Artificial cells, nanomedicine, and biotechnology.

New Approaches to the Immunotherapy of Type 1 Diabetes Mellitus Using Interleukin-27.

Tohid Kazemi, S. Almasi, M. Aliparasti, 2015, Advanced pharmaceutical bulletin.

Circulating myeloid‐derived suppressor cells: An independent prognostic factor in patients with breast cancer

P. Duijf, B. Baradaran, M. Yousefi, 2018, Journal of cellular physiology.

Restoration of miRNA-143 Expression Inhibits Growth and Migration of MKN-45 Gastric Cancer Cell Line

B. Baradaran, D. Shanehbandi, B. Mansoori, 2020, Advanced pharmaceutical bulletin.

Low representation of Fc receptor-like 1–5 molecules in leukemic cells from Iranian patients with acute lymphoblastic leukemia

M. Shabani, P. Vossough, R. Sharifian, 2009, Cancer Immunology, Immunotherapy.

Fc receptor‐like 1–5 molecules are similarly expressed in progressive and indolent clinical subtypes of B‐cell chronic lymphocytic leukemia

S. Razavi, M. Shabani, R. Sharifian, 2008, International journal of cancer.

PD-1/PD-L1 axis importance and tumor microenvironment immune cells.

B. Baradaran, D. Shanehbandi, A. Mokhtarzadeh, 2020, Life sciences.

PD-L1 silencing inhibits triple-negative breast cancer development and upregulates T-cell-induced pro-inflammatory cytokines.

B. Baradaran, A. Derakhshani, Siamak Sandoghchian Shotorbani, 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Prognostic Role and Clinical Significance of Tumor-Infiltrating Lymphocyte (TIL) and Programmed Death Ligand 1 (PD-L1) Expression in Triple-Negative Breast Cancer (TNBC): A Systematic Review and Meta-Analysis Study

B. Baradaran, A. Baghbanzadeh, M. Asghari jafarabadi, 2020, Diagnostics.

Silencing of BACH1 inhibits invasion and migration of prostate cancer cells by altering metastasis-related gene expression

P. Duijf, B. Baradaran, D. Shanehbandi, 2018, Artificial cells, nanomedicine, and biotechnology.

Tumor‐derived exosomes: Implication in angiogenesis and antiangiogenesis cancer therapy

F. Sigaroodi, Farhad Salari, Houman Kahroba, 2019, Journal of cellular physiology.

Toxoplasmosis and Alzheimer: can Toxoplasma gondii really be introduced as a risk factor in etiology of Alzheimer?

H. Sadeghi-Bazargani, M. Talebi, M. Farhoudi, 2016, Parasitology Research.

The correlation between Toxoplasma gondii infection and Parkinson’s disease: a case-control study

H. Sadeghi-Bazargani, M. Talebi, M. Farhoudi, 2016, Journal of Parasitic Diseases.

Regulatory interplay between microRNAs and WNT pathway in glioma.

Tohid Kazemi, Peyman Tabnak, Asrin Mafakheri, 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Let-7a could serve as a biomarker for chemoresistance against docetaxel in gastric cancer.

B. Baradaran, D. Shanehbandi, V. Khaze, 2018, Anti-cancer agents in medicinal chemistry.

microRNA‐193a‐5p inhibits migration of human HT‐29 colon cancer cells via suppression of metastasis pathway

B. Baradaran, D. Shanehbandi, B. Mansoori, 2018, Journal of cellular biochemistry.

CD20-based Immunotherapy of B-cell Derived Hematologic Malignancies.

B. Baradaran, D. Shanehbandi, L. Aghebati-Maleki, 2017, Current cancer drug targets.

Immuno-biosensor for Detection of CD20-Positive Cells Using Surface Plasmon Resonance

Farzaneh Fathi, B. Baradaran, D. Shanehbandi, 2017, Advanced pharmaceutical bulletin.

Cloning and molecular characterization of the cDNAs encoding the variable regions of an anti-CD20 monoclonal antibody.

B. Baradaran, D. Shanehbandi, L. Aghebati-Maleki, 2017, Human Antibodies.

HER2 positivity may confer resistance to therapy with paclitaxel in breast cancer cell lines

B. Baradaran, D. Shanehbandi, D. Elieh Ali Komi, 2018, Artificial cells, nanomedicine, and biotechnology.

Toxicopathological Changes Induced By Combined Exposure To Noise and Toluene in New Zealand White Rabbits

Y. Rasoulzadeh, M. Mesgari-Abbasi, Tohid Kazemi, 2022, Arhiv za higijenu rada i toksikologiju.

HMGA2 and Bach‐1 cooperate to promote breast cancer cell malignancy

P. Duijf, B. Baradaran, Zahra Asadzadeh, 2019, Journal of cellular physiology.

STAT3 Silencing and TLR7/8 Pathway Activation Repolarize and Suppress Myeloid-Derived Suppressor Cells From Breast Cancer Patients

P. Duijf, B. Baradaran, A. Derakhshani, 2021, Frontiers in Immunology.

Fc-fusion Proteins in Therapy: An Updated View.

H. Rafatpanah, J. Majidi, R. Jafari, 2017, Current medicinal chemistry.

Characterization of novel murine monoclonal antibodies directed against the extracellular domain of human HER2 tyrosine kinase receptor.

J. Khoshnoodi, M. Jeddi-Tehrani, Hodjatallah Rabbani, 2011, Hybridoma.

Differential altered expression of let-7a and miR-205 tumor-suppressor miRNAs in different subtypes of breast cancer under treatment with Taxol.

B. Baradaran, V. Khaze, Tohid Kazemi, 2018, Advances in clinical and experimental medicine : official organ Wroclaw Medical University.

Study of the Effect of Linoleic Acid on the Expression Level of MicroRNA-106b and MicroRNA-20a and their Related Target MHC Class I Chain-related Protein A in Docetaxel-treated Gastric Cancer Cells

B. Sepehri, Tohid Kazemi, M. Shirmohamadi, 2021 .

Synergistic Beneficial Effect of Docosahexaenoic Acid (DHA) and Docetaxel on the Expression Level of Matrix Metalloproteinase-2 (MMP-2) and MicroRNA-106b in Gastric Cancer

B. Baradaran, M. Darabi, Mahsa Javadian, 2019, Journal of Gastrointestinal Cancer.

Circulating MicroRNAs: Valuable Biomarkers for the Diagnosis and Prognosis of Gastric Cancer.

B. Baradaran, D. Shanehbandi, Tohid Kazemi, 2017, Current medicinal chemistry.

Paclitaxel May Inhibit Epithelial-Mesenchymal Transition Properties of Triple-negative Breast Cancer Cell Line via Altering the Expression of EMT-promoting and –inhibiting MicroRNAs

D. Shanehbandi, A. Mohammadi, Mahsa Javadian, 2020 .

The induced decrease in TLR2 and TLR4 by cerebrolysin in the alcoholic liver of rats

Huaxi Xu, S. Sadigh-Eteghad, Siamak Sandoghchian Shotorbani, 2019, Journal of cellular physiology.

Protective effect of a DNA vaccine cocktail encoding ROP13 and GRA14 with Alum nano-adjuvant against Toxoplasma gondii infection in mice.

A. Daryani, E. Ahmadpour, M. L. Pereira, 2021, The international journal of biochemistry & cell biology.

The combination effect of Prominin1 (CD133) suppression and Oxaliplatin treatment in colorectal cancer therapy.

B. Baradaran, D. Shanehbandi, A. Mokhtarzadeh, 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Investigation of IL-21 gene polymorphisms (rs2221903, rs2055979) in cases with multiple sclerosis of Azerbaijan, Northwest Iran.

M. Farhoudi, Z. Babaloo, Tohid Kazemi, 2015, American journal of clinical and experimental immunology.

IL-17 and IL-22 Elicited by a DNA vaccine encoding ROP 13 associate with protection 1 against Toxoplasma gondii in BALB / c mice 2 3

A. Daryani, A. Spotin, E. Ahmadpour, 2019 .

In vitro assessment of the effects of anti-HER2 monoclonal antibodies on proliferation of HER2-overexpressing breast cancer cells.

M. M. Amiri, J. Khoshnoodi, M. Jeddi-Tehrani, 2014, Immunotherapy.

Tumor suppressor microRNAs: Targeted molecules and signaling pathways in breast cancer.

B. Baradaran, M. Hemmatzadeh, Tohid Kazemi, 2016, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

NANOG gene suppression and replacement of let-7 modulate the stemness, invasion, and apoptosis in breast cancer.

B. Baradaran, Souzan Najafi, E. Baghbani, 2021, Gene.

Evaluation of ERAP1 Gene Single Nucleotide Polymorphism in Impressing the Inflammatory Cytokine Profile of Ankylosing Spondylitis Patients.

B. Baradaran, M. Yousefi, E. Baghbani, 2018, Iranian journal of allergy, asthma, and immunology.

Construction and characterization of a new chimeric antibody against HER2.

J. Khoshnoodi, M. Jeddi-Tehrani, Hodjatallah Rabbani, 2013, Immunotherapy.

Relation between Immune cell response and stemness genes expression in breast cancer; A new approach in NANOG gene and Let7-a expression in breast cancer cell lines

B. Baradaran, Souzan Najafi, Zeynab Aliyari-Serej, 2020 .

VISTA and its ligands: the next generation of promising therapeutic targets in immunotherapy

B. Baradaran, D. Shanehbandi, S. Jalali, 2023, Cancer Cell International.

Preparation of Proper Immunogen by Cloning and Stable Expression of cDNA coding for Human Hematopoietic Stem Cell Marker CD34 in NIH-3T3 Mouse Fibroblast Cell Line.

D. Shanehbandi, J. Majidi, Tohid Kazemi, 2015, Advanced pharmaceutical bulletin.

Development of a Stable Cell Line, Overexpressing Human T-cell Immunoglobulin Mucin 1.

H. Khanahmad, M. Ganjalikhani-Hakemi, V. Homayouni, 2015, Iranian journal of biotechnology.

STATs signaling pathways in dendritic cells: As potential therapeutic targets?

B. Baradaran, Leili Aghebati Maleki, Tohid Kazemi, 2023, International reviews of immunology.

BACH1 silencing by siRNA inhibits migration of HT-29 colon cancer cells through reduction of metastasis-related genes.

B. Baradaran, D. Shanehbandi, B. Mansoori, 2016, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Unmasking the NLRP3 inflammasome in dendritic cells as a potential therapeutic target for autoimmunity, cancer, and infectious conditions.

Tohid Kazemi, Amirhossein Mardi, Javad Masoumi, 2024, Life sciences.

Exploring the dynamic interplay between exosomes and the immune tumor microenvironment: implications for breast cancer progression and therapeutic strategies

B. Baradaran, D. Shanehbandi, Tohid Kazemi, 2024, Breast cancer research : BCR.

Glyburide-treated human monocyte-derived dendritic cells loaded with insulin represent tolerogenic features with anti-inflammatory responses and modulate autologous T cell responses in vitro.

B. Baradaran, E. Baghbani, Tohid Kazemi, 2023, International immunopharmacology.

Docosahexaenoic acid (DHA) impairs hypoxia-induced cellular and exosomal overexpression of immune-checkpoints and immunomodulatory molecules in different subtypes of breast cancer cells

Tohid Kazemi, Sepideh Maralbashi, N. Haghnavaz, 2024, BMC nutrition.

Gene therapy, early promises, subsequent problems, and recent breakthroughs.

B. Baradaran, L. Mohammadnejad, F. Lotfipour, 2013, Advanced pharmaceutical bulletin.

Pharmacological and therapeutic potentials of cordycepin in hematological malignancies.

Tohid Kazemi, Saeed Solali, Manouchehr Fadaee, 2023, Biochemical and biophysical research communications.

Determination of IL-23 receptor expression and gene polymorphism (rs1884444) in Iranian patients with ankylosing spondylitis

S. Soltani, E. Farhadi, M. Akhtari, 2024, BMC rheumatology.

Access to the Published Version May Require Subscription. Published with Permission From: Future Medicine Construction and Characterization of a New Chimeric Antibody against Her2 2 Materials and Methods

J. Khoshnoodi, M. Jeddi-Tehrani, Hodjatallah Rabbani, 2022 .